FDA warns Earth City, MO-based Legacy Pharmaceutical Packaging about CGMP violations and insanitary conditions in its manufacturing of finished drugs.
FDA extends the deadline for comments on a draft guidance intended to improve labeling for LASIK devices used in vision correction.
The Washington DC District Court rules against FDA in granting summary judgment to plaintiff Melinta Therapeutics that suspends the approval of a gene...
FDA explains why it is proposing to refuse to approve a Vanda sNDA for a new indication for Hetlioz.
The Outsourcing Facilities Association and FDA reach a settlement agreement that compels the agency to promptly review long-pending nominations for ac...
Hyman, Phelps & McNamara attorneys and a medical device regulatory expert say an FDA final guidance on clinical decision support software will generat...
Reuters reports that FDA has again found quality issues at the Lilly Branchburg, NJ, drug manufacturing facility.
FDA accepts for priority review a Gilead Sciences supplemental BLA for Trodelv (sacituzumab govitecan-hziy) for treating certain adult patients with u...
